Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AMR Roundtable Part 1: Incentives Spur Antimicrobial Investments, But More Needed

Jul 14 2017

• By Mandy Jackson

Antibiotic resistant bacteria closeup biofilm

Related Content

Actavis Counting On Strong Product Line Depth For <em>Avycaz</em> Launch

Mar 09 2015

Podcast: Accelerating Antibiotics – Kevin Outterson And Joe Larsen Explain CARB-X

Mar 31 2017

CARB-X Partnership Puts Antibiotics' Future In Biotech Startups' Hands

Jul 30 2016

Actavis builds antibiotic presence with $675m+ Durata deal

Oct 07 2014

CMS Denial of Astellas’ Cresemba Add-On Payment Could Boost Legislative Solution

Aug 12 2015

With more cha-ching, will PDUFA V satisfy on the ba-bling?

Jul 19 2012

Related Companies

Amplyx Pharmaceuticals, Inc.

Cidara Therapeutics, Inc.

Astellas Pharma, Inc.

Allergan plc

Additional Topics

Business Strategies Commercial Financing StartUps and SMEs Infectious Diseases BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window